2415 — MedSci Healthcare Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$985.95m
- -HK$228.41m
- CNY349.19m
- 72
- 65
- 15
- 49
Annual cashflow statement for MedSci Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 33.2 | -147 | -96.3 | 60.5 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | -1.54 | 200 | 108 | -15.9 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 17.5 | -23.9 | -34.3 | -14.9 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 56.2 | 37.4 | -14 | 38 |
| Capital Expenditures | -1.11 | -0.889 | -2.16 | -1.95 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 32.5 | -1.15 | 0.031 | -493 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 31.4 | -2.03 | -2.13 | -495 |
| Financing Cash Flow Items | 0 | -3.88 | 0 | 520 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 93.1 | 286 | -7.52 | 471 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 181 | 319 | 3.26 | 29.3 |